Rchr
J-GLOBAL ID:201801013674040612   Update date: May. 17, 2021

Tashiro Haruko

Tashiro Haruko
Affiliation and department:
Research field  (1): Hematology and oncology
Research keywords  (4): hematological malignancy ,  Acute Myeloid Leukemia ,  Cell therapy ,  Gene therapy
Research theme for competitive and other funds  (2):
  • 2020 - 2023 急性骨髄性白血病に対するCLL-1特異的キメラ抗原受容体T細胞療法の改良
  • 2016 - 2018 gene introduction using myeloid lineage cells
Papers (38):
  • Sumiko Saito, Haruko Tashiro, Ritsu Sumiyoshi, Takuji Matsuo, Tadashi Yamamoto, Kensuke Matsumoto, Jun Ooi, Naoki Shirafuji. Second allogeneic transplantation using umbilical cord blood for a patient with relapsed ALK+ anaplastic large cell lymphoma after allogeneic bone marrow transplantation in the era of ALK inhibitors: A case report. Medicine. 2021. 100. 15. e25576
  • Aiko Hasegawa, Shoji Saito, Shogo Narimatsu, Shigeru Nakano, Mika Nagai, Hideki Ohnota, Yoichi Inada, Hirokazu Morokawa, Ikumi Nakashima, Daisuke Morita, et al. Mutated GM-CSF-based CAR-T cells targeting CD116/CD131 complexes exhibit enhanced anti-tumor effects against acute myeloid leukaemia. Clinical & translational immunology. 2021. 10. 5. e1282
  • Takuji Matsuo, Haruko Tashiro, Ritsu Sumiyoshi, Sumiko Saito, Ryosuke Shirasaki, Naoki Shirafuji. Functional expression cloning of molecules inducing CD34 expression in bone marrow-derived stromal myofibroblasts. Biochemical and biophysical research communications. 2020. 533. 4. 1283-1289
  • Yoko Miura, Jun Ooi, Takuji Matsuo, Tadashi Yamamoto, Ritsu Sumiyoshi, Sumiko Saito, Kensuke Matsumoto, Haruko Tashiro, Naoki Shirafuji. Successful myeloablative unrelated bone marrow transplantation for relapsed intravascular large B cell lymphoma after autologous peripheral blood stem cell transplantation. Annals of hematology. 2020
  • Pinar Ataca Atilla, Mary K McKenna, Haruko Tashiro, Madhuwanti Srinivasan, Feiyan Mo, Norihiro Watanabe, Brian Wesley Simons, Alexandra McLean Stevens, Michele S Redell, Helen E Heslop, et al. Modulating TNFα activity allows transgenic IL15-Expressing CLL-1 CAR T cells to safely eliminate acute myeloid leukemia. Journal for immunotherapy of cancer. 2020. 8. 2
more...
MISC (138):
more...
Professional career (1):
  • 医学博士 (帝京大学医学部)
Association Membership(s) (6):
THE JAPANESE SOCIETY OF INTERNAL MEDICINE ,  THE JAPANESE SOCIETY FOR REGENERATIVE MEDICINE ,  JAPAN SOCIETY OF GENE AND CELL THERAPY ,  THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY ,  THE JAPAN SOCIETY OF HEMATOPIETIC CELL TRANSPLANTATION ,  THE JAPANESE SOCIETY OF HEMATOLOGY
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page